Pharmaceutical Science is a relatively new discipline and is concerned with fostering a multi-disciplinary approach towards the study of exciting new developments in the chemical, biological and biomedical science areas focusing upon the biochemistry, pharmacology, design, methods of analysis and delivery of pharmaceutical substances. The course aims to produce high quality pharmaceutical science graduates with the generic, subject-specific and transferable knowledge and skills suited to a career in the pharmaceutical industry or other related laboratory based scientific discipline.
The course provides two routes, leading to a named award in Pharmaceutical Science, appropriate for students already in, or planning a career in the Pharmaceutical Sciences profession. The route options are:
Your modules will include:
The course will provide you with a thorough grounding in the basic principles of Pharmaceutical Science and will equip you with the skills necessary for successful postgraduate study. Pharmaceutical science is well established at Wolverhampton and benefits from a long tradition of teaching and research in the chemical and biological sciences. This course gives students an excellent opportunity to study core science as well as the modern developments that are occurring at the boundaries between biology, chemistry and clinical practice.
The Pharmaceutical Science course is attractive if you are seeking an academic research career and/or wish to make yourself highly employable as a pharmaceutical scientist, enabling you to specialize in the key area of pharmacological sciences.
Specialist modules offer you the opportunity to gain knowledge in key and emerging areas of Pharmaceutical Science, focussing on Pharmacological Sciences.
Normally, you should have a minimum 2:2 Honours degree or equivalent.
We look for graduates with an appropriate Honours degree in chemistry, biochemistry, pharmacology, biological or biomedical subjects.
You should have a good standard of written and spoken English (IELTS 6.5 or equivalent).
These fees are applicable for new entrants in 2017/8. Fees are for the academic year only, any subsequent years may be subject to an annual increase, usually in line with inflation.
Professional and Career Development Loan: The University is a Professional and Career Development Loans (PCDL) registered Learning Provider, registration number . A PCDL is a commercial bank loan that you can use to help pay for work-related learning. For further information on financial assistance to support your learning, please visit the GOV.UK website or contact the National Careers Service on 0800 100 900.
Charitable Funding: You might also want to explore the possibility of funding from charitable trusts; please see the following websites www.acf.org.uk, www.dsc.org.uk/fundingwebsites or www.family-action.org.uk. Most charities and trust funds offer limited bursaries targeted to specific groups of students so you will need to research whether any of them are relevant to your situation.
University Postgraduate Loyalty Discount: The University also offers a postgraduate loyalty discount (http://www.wlv.ac.uk/study-here/money-matters/financial-support/postgraduate-study/postgraduate-loyalty-discount/): If you have completed an undergraduate degree at the University of Wolverhampton, you may be eligible for a 20% discount on the first year of a taught postgraduate programme.
Financial Hardship: Students can apply to the Dennis Turner Opportunity Fund (http://www.wlv.ac.uk/study-here/money-matters/financial-support/dennis-turner-opportunity-fund/) for help with course related costs however this cannot be used for fees or to cover general living costs.
If you are paying for the fees yourself then the fees can be paid in 3 instalments: November, January and April. More information can be found at www.wlv.ac.uk/howtopay.
The University has 40 Postgraduate Science, Technology, Engineering and Maths (STEM) fee scholarships to award to eligible full and part-time applicants who confirm their place by the 18th August 2014 to start their studies in October 2014/5